Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
Allogeneic Stem Cell Transplantation in Relapsed/Refractory T-, NK/T-cell Lymphomas
- Status
- RECRUITING
- Phase
- PHASE2
E7 TCR T Cells for Human Papillomavirus-Associated Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Allogenic Immunotherapy Based on Natural Killer (NK) Cell Adoptive Transfer in Metastatic Gastrointestinal Carcinoma Treated With Cetuximab
- Status
- COMPLETED
- Phase
- PHASE1
Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia
- Status
- COMPLETED
- Phase
- NA
Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme
- Status
- UNKNOWN
- Phase
- PHASE1
NMA Haplo or MUD BMT for Newly Diagnosed Severe Aplastic Anemia
- Status
- COMPLETED
- Phase
- PHASE2
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia
- Status
- RECRUITING
- Phase
- PHASE2
HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide
- Status
- COMPLETED
- Phase
- PHASE2
Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Safety Study of Human Cord Blood Derived, Culture Expanded Natural Killer Cell (PNK-007) Infusion With Subcutaneous Recombinant Human IL-2 (rhIL-2) in Adults With Relapsed and/or Refractory Acute Myeloid Leukemia (AML)
- Status
- TERMINATED
- Phase
- PHASE1
Lymphodepletion and Anti-PD-1 Blockade to Reduce Relapse in AML Patient Not Eligible for Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)
- Status
- COMPLETED
- Phase
- PHASE2
NK Cells as Consolidation Therapy of Acute Myeloid Leukemia in Children/Adolescents
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Trial of Anti-GD2 T-cells (1RG-CART)
- Status
- COMPLETED
- Phase
- PHASE1
Azacitidine in Haploidentical Donor Hematopoietic Cell Transplantation
- Status
- TERMINATED
- Phase
- PHASE1
Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia
- Status
- RECRUITING
- Phase
- PHASE3
UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep
- Status
- COMPLETED
- Phase
- PHASE2